Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1307765rdf:typepubmed:Citationlld:pubmed
pubmed-article:1307765lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:1307765lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:1307765lifeskim:mentionsumls-concept:C0014544lld:lifeskim
pubmed-article:1307765lifeskim:mentionsumls-concept:C0003286lld:lifeskim
pubmed-article:1307765lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:1307765lifeskim:mentionsumls-concept:C0037567lld:lifeskim
pubmed-article:1307765lifeskim:mentionsumls-concept:C1879746lld:lifeskim
pubmed-article:1307765lifeskim:mentionsumls-concept:C1547011lld:lifeskim
pubmed-article:1307765pubmed:issue2lld:pubmed
pubmed-article:1307765pubmed:dateCreated1993-9-16lld:pubmed
pubmed-article:1307765pubmed:abstractTextThe serum valproate (VPA) concentration and the clinical effects of polytherapy with other antiepileptic drugs: phenobarbital (PB), clonazepam (CZP), diazepam (DZ), clobazam (CLO), ethosuximide (ESX) were estimated. VPA serum levels were reduced when this drug was combined with phenobarbital. Clobazam given together with valproate led to an increase in the serum concentration of the former drug. VPA serum levels were without significant changes when the drug was combined with either ethosuximide or 1-4-benzodiazepines. The best therapeutical effects were found after polytherapy sodium valproate with ethosuximide and clobazam in primary generalized seizures.lld:pubmed
pubmed-article:1307765pubmed:languageenglld:pubmed
pubmed-article:1307765pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1307765pubmed:citationSubsetIMlld:pubmed
pubmed-article:1307765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1307765pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1307765pubmed:statusMEDLINElld:pubmed
pubmed-article:1307765pubmed:issn0025-5246lld:pubmed
pubmed-article:1307765pubmed:authorpubmed-author:SobaniecWWlld:pubmed
pubmed-article:1307765pubmed:issnTypePrintlld:pubmed
pubmed-article:1307765pubmed:volume24lld:pubmed
pubmed-article:1307765pubmed:ownerNLMlld:pubmed
pubmed-article:1307765pubmed:authorsCompleteYlld:pubmed
pubmed-article:1307765pubmed:pagination115-9lld:pubmed
pubmed-article:1307765pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1307765pubmed:meshHeadingpubmed-meshheading:1307765-...lld:pubmed
pubmed-article:1307765pubmed:meshHeadingpubmed-meshheading:1307765-...lld:pubmed
pubmed-article:1307765pubmed:meshHeadingpubmed-meshheading:1307765-...lld:pubmed
pubmed-article:1307765pubmed:meshHeadingpubmed-meshheading:1307765-...lld:pubmed
pubmed-article:1307765pubmed:meshHeadingpubmed-meshheading:1307765-...lld:pubmed
pubmed-article:1307765pubmed:meshHeadingpubmed-meshheading:1307765-...lld:pubmed
pubmed-article:1307765pubmed:meshHeadingpubmed-meshheading:1307765-...lld:pubmed
pubmed-article:1307765pubmed:meshHeadingpubmed-meshheading:1307765-...lld:pubmed
pubmed-article:1307765pubmed:meshHeadingpubmed-meshheading:1307765-...lld:pubmed
pubmed-article:1307765pubmed:meshHeadingpubmed-meshheading:1307765-...lld:pubmed
pubmed-article:1307765pubmed:meshHeadingpubmed-meshheading:1307765-...lld:pubmed
pubmed-article:1307765pubmed:articleTitleCertain aspects of interaction between sodium valproate and other anticonvulsant drugs in the therapy of epilepsy in children.lld:pubmed
pubmed-article:1307765pubmed:affiliationDepartment of Neurology, Medical Academy, Bia?ystok, Poland.lld:pubmed
pubmed-article:1307765pubmed:publicationTypeJournal Articlelld:pubmed